New skin treatment enters testing phase against established drug
Disease control
Recruiting now
This early-stage study aims to see if a new drug called GS101 works similarly to the existing treatment Dupixent for atopic dermatitis (eczema). Researchers will compare how the body processes both drugs, their safety, and immune responses in 294 healthy adult men in China. This …
Phase: PHASE1 • Sponsor: Jiangsu Genscend Biopharmaceutical Co., Ltd • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC